Gilberto Lopes, Chief of the Division of Medical Oncology at the Sylvester Comprehensive Cancer Center, shared on LinkedIn:
“November is Lung Cancer Awareness Month.
New treatments are changing what is possible in lung cancer.
For one patient, a plan combining radiation and chemotherapy with immunotherapy cleared her scans just seven months after diagnosis.
New studies of these immunotherapies suggest that maybe 15% – maybe more – of patients are alive at five years, and may even be cured.
From my Focusing on You conversation at the University of Miami.”
You can also read: Neoadjuvant Immunotherapy Linked to Improved Five-Year Survival in Resected NSCLC: Real-World Study Supports Long-Term Benefit Without Increased Surgical Morbidity
